A detailed history of Main Street Research LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Main Street Research LLC holds 9,722 shares of ABBV stock, worth $1.89 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
9,722
Previous 9,984 2.62%
Holding current value
$1.89 Million
Previous $1.82 Million 8.31%
% of portfolio
0.11%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $40,554 - $47,359
-262 Reduced 2.62%
9,722 $1.67 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $27,169 - $30,957
-170 Reduced 1.67%
9,984 $1.82 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $47,196 - $53,154
343 Added 3.5%
10,154 $1.57 Million
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $801 - $927
6 Added 0.06%
9,811 $1.46 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $254,949 - $317,267
-1,924 Reduced 16.4%
9,805 $1.32 Million
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $14,750 - $16,987
-102 Reduced 0.86%
11,729 $1.87 Million
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $40,248 - $48,268
-291 Reduced 2.4%
11,831 $1.91 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $91,799 - $105,288
684 Added 5.98%
12,122 $1.63 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $10,459 - $13,296
76 Added 0.67%
11,438 $1.75 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $188,203 - $233,507
-1,426 Reduced 11.15%
11,362 $1.84 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $225,603 - $285,453
2,100 Added 19.65%
12,788 $1.73 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1.09 Million - $1.23 Million
-10,205 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $30,826 - $34,342
293 Added 2.96%
10,205 $1.15 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $9,513 - $10,473
-93 Reduced 0.93%
9,912 $1.07 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $23,181 - $31,296
-288 Reduced 2.8%
10,005 $1.07 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $884,271 - $1.04 Million
10,293 New
10,293 $902,000
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $177,408 - $237,399
2,418 Added 31.03%
10,210 $1 Million
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $23,800 - $36,084
369 Added 4.97%
7,792 $594,000
Q4 2019

Jan 28, 2020

SELL
$72.13 - $90.25 $51,933 - $64,980
-720 Reduced 8.84%
7,423 $657,000
Q3 2019

Oct 21, 2019

SELL
$62.98 - $75.72 $569,528 - $684,735
-9,043 Closed
0 $0
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $594,125 - $759,431
9,043 New
9,043 $658,000
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $30,084 - $35,408
390 Added 4.78%
8,543 $688,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $12.6 Million - $15.6 Million
-162,030 Closed
0 $0
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $1.02 Million - $1.13 Million
11,449 Added 7.6%
162,030 $15.3 Million
Q2 2018

Jul 25, 2018

SELL
$89.78 - $106.23 $133,323 - $157,751
-1,485 Reduced 0.98%
150,581 $14 Million
Q1 2018

May 08, 2018

BUY
$92.01 - $123.21 $689,246 - $922,966
7,491 Added 5.18%
152,066 $14.4 Million
Q4 2017

Feb 05, 2018

BUY
$89.56 - $98.21 $218,884 - $240,025
2,444 Added 1.72%
144,575 $14 Million
Q3 2017

Oct 16, 2017

BUY
$69.85 - $89.22 $9.93 Million - $12.7 Million
142,131
142,131 $12.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Main Street Research LLC Portfolio

Follow Main Street Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Research LLC with notifications on news.